Data on retreatment with TDXd after grade 1 ILD from a pooled analysis presented by Hope Rugo demonstrates that 67% retreated without ILD recurrence #ESMOBreast24 OncoAlert #bcsm

Honored to be appointed Associate Professor of Oncology at Mayo Clinic - Sid Yadav MD, FACP Fergus Couch Matthew Goetz Mayo Clinic oncodaily.com/65608.html #Cancer #OncoDaily #Oncology #MayoClinic #Leadership

Honored to be part of ASCO Guideline Panel for selection of germline genetic testing panels in patients with cancer. Provides direct, comprehensible guidance for oncologists and other health practitioners. bit.ly/4av5utJ Journal of Clinical Oncology ASCO OncoAlert

Learning something new every molecular mdt ! Great way to keep up with all that’s going on in the genomics world across tumour sites and try and deliver best for our patients ! So grateful for inputs from experts all over india and globally 🙏🏽🙏🏽 selflessly making a huge effort

One of the most important presentations of #ASCO24: expansion cohorts from TBCRC 048, presented by Nadine Tung MD Among pts with MBC, olaparib achieved: - ORR 76% in gPALB2 mut carriers - ORR 37% in sBRCA mut carriers Terrific effort from Translational Breast Cancer Research Consortium (make sure to follow for more!)

From JAMA: USPSTF recommends all women undergo routine #breastcancer screening every other year beginning at age 40, an update from the 2016 recommendation to start at age 50. ja.ma/45mG9BB

Just got done with a meeting with⁩ before boarding the plane to Minneapolis for our official Best of ASCO, Minneapolis. Thank you ⁦Sid Yadav MD, FACP⁩ CancerGeneticsDoc for supporting fundraising efforts for construction of 200-bed ⁦Binaytara Foundation⁩ cancer hospital in Nepal.

Looking forward to the officially licensed Best of ASCO in Minneapolis this weekend. We have an exciting line up of speakers and talks! Join us if you are in the area.

Dr Sid Yadav MD, FACP kicks off the #BestofASCO, Minneapolis

Outstanding talk Hamza Hashmi I loved the way you highlighted 5 abstracts with personal commentary.

Amazing talks! Dr. Molina (Mayo Clinic Comprehensive Cancer Center) Dr. Kratzke (Masonic Cancer Center, University of Minnesota ) and Dr. Ji (HealthPartners ) provide a comprehensive insight on the landscape of upcoming treatments for lung cancer at the #BestofASCO in Minneapolis.

Outstanding talk by Sid Yadav MD, FACP of Mayo Clinic. He does a fantastic job reviewing the abstracts presented at ASCO and adds his perspective on how the data can be applied in clinics.

JUST IN: U.S. FDA approved pembrolizumab with carboplatin+paclitaxel, followed by single-agent pembrolizumab, for patients with metastatic Endometrial Carcinoma based on KEYNOTE-868/NRG-GY018. PFS HR 0.3 (dMMR) and 0.6 (pMMR), both p<0.0001. fda.gov/drugs/resource…

The 10 biggest cancer papers of the last 10 years (in my opinion) 1. Blocking PD1 activates the immune response against cancer - especially if the cancer has more mutations nejm.org/doi/pdf/10.105…

The Conquer Cancer, the ASCO Foundation YIA was instrumental in shaping my academic career. I’m thrilled to see that the award will now be available to many more young researchers. Thank you Lynn Schuchter for traveling all the way from Philly, Jasmine Kamboj for hosting & MSCO for the support.

Sid Yadav MD, FACP Conquer Cancer, the ASCO Foundation Lynn Schuchter Thanks so much for sharing your story, Sid! Very powerful indeed. Researchers like yourself make oncology so successful!

Thanks Conquer Cancer, the ASCO Foundation Lynn Schuchter Senator Amy Klobuchar Sid Yadav MD, FACP Anastasios Dimou MSCO Board for making this event so successful!

Dr. Siddhartha Yadav on Genomic Assessment of Drug Sensitivity Shaheenah Dawood Ben Westphalen Fen Saj Sid Yadav MD, FACP bhawna sirohi youtu.be/0DoUvTQyGM0?si…

Two weeks to #ESMO24. Multiple important breast onc trials readouts across disease subtypes, including OS from KN522, DB12, 4y of NATALEE, CAPItello290, phase 1 studies of novel ADCs, IO, targeted drugs, and so much more. The countdown is on. See you soon in Barcelona! 🇪🇸 #bcsm

We invite you to complete a brief survey to help us identify your needs and priorities for Binaytara Foundation's upcoming Summit on Cancer Health Disparities. Your insights will be used to design a program that addresses critical issues, provides practical solutions, and fosters